Antisense Therapeutics Limited Stock Current Liabilities
Antisense Therapeutics Limited fundamentals help investors to digest information that contributes to Antisense Therapeutics' financial success or failures. It also enables traders to predict the movement of Antisense Pink Sheet. The fundamental analysis module provides a way to measure Antisense Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Antisense Therapeutics pink sheet.
Antisense |
Antisense Therapeutics Limited Company Current Liabilities Analysis
Antisense Therapeutics' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Antisense Therapeutics Current Liabilities | 1000 K |
Most of Antisense Therapeutics' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Antisense Therapeutics Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Antisense Therapeutics Limited has a Current Liabilities of 1000 K. This is 99.94% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current liabilities for all United States stocks is 99.99% higher than that of the company.
Antisense Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Antisense Therapeutics' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Antisense Therapeutics could also be used in its relative valuation, which is a method of valuing Antisense Therapeutics by comparing valuation metrics of similar companies.Antisense Therapeutics is currently under evaluation in current liabilities category among its peers.
Antisense Fundamentals
Return On Equity | -0.43 | |||
Return On Asset | -0.25 | |||
Operating Margin | (3.28) % | |||
Current Valuation | 27.82 M | |||
Shares Outstanding | 669.04 M | |||
Shares Owned By Insiders | 19.30 % | |||
Shares Owned By Institutions | 4.93 % | |||
Price To Earning | (3.62) X | |||
Price To Book | 3.05 X | |||
Price To Sales | 24.46 X | |||
Revenue | 1.78 M | |||
Gross Profit | 1.71 M | |||
EBITDA | (7.52 M) | |||
Net Income | (5.81 M) | |||
Cash And Equivalents | 19.23 M | |||
Cash Per Share | 0.03 X | |||
Total Debt | 227.4 K | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 19.14 X | |||
Book Value Per Share | 0.03 X | |||
Cash Flow From Operations | (7.81 M) | |||
Earnings Per Share | (0.01) X | |||
Number Of Employees | 12 | |||
Beta | 0.67 | |||
Market Capitalization | 41.78 M | |||
Total Asset | 22.44 M | |||
Retained Earnings | (53 M) | |||
Working Capital | 4 M | |||
Current Asset | 5 M | |||
Current Liabilities | 1000 K | |||
Net Asset | 22.44 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Antisense Pink Sheet
If you are still planning to invest in Antisense Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Antisense Therapeutics' history and understand the potential risks before investing.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world |